![](/img/cover-not-exists.png)
Multicenter study of subcutaneous alemtuzumab administered at reduced dose in patients with fludarabine-relapsed/refractory chronic lymphocytic leukemia: final analysis
Bezares, Raimundo Fernando, Stemelin, German, Diaz, Alicia, Argentieri, Daniel, Zubiaur, Emilio Lanari, Garay, Guy, Bartomioli, Miguel, Ryser, Ricardo, Milone, GustavoVolume:
52
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2011.584991
Date:
October, 2011
File:
PDF, 287 KB
english, 2011